Abstract submission deadline: 1 May 2018 – 15 Jan 2019 (CLOSED)
Abstract reviewal and notification: 15 Jan – 25 Jan 2019 (CLOSED)
PLEASE READ THIS THROUGHLY BEFORE PREPARING YOUR ABSTRACT
1. Only abstracts written in English will be accepted.
2. The abstract itself must contain no more than 250 words.Table and figures are not allowed.
3. CAPITALIZE the entire title and UNDERLINE the name of author who will present the paper. Abbreviations must not be used in the title. After the title, list the author’s names and institutional affiliations; OMIT degrees, titles, institutional appointments, address and zip code. The text should be typed using single spacing. Do not indent the title and each paragraph.
4. Abbreviations must be defined by placing them in parentheses after the full word the first time they appear. Use numerals to indicate numbers except when beginning sentences.
5. Nonproprietary (generic) names, written in lower-case letters, are required the first time a drug is mentioned. Proprietary names are always capitalized.
6. Abstract will appear exactly as submitted. Abstract with smudges, errors, misspellings, incorrect hyphenations, faint typing, etc. (or not conforming to the prescribed rules) will require retyping at the author’s expense
7. CHECK ONE KEY WORD in the abstract submission form, which best categorizes the subject of the abstract.
8. All accepted abstracts will be published in the conference e-abstract book.
ONLINE ABSTRACT SUBMISSION: